JPMORGAN CHASE & CO - BRIDGEBIO PHARMA INC ownership

Back to all holdings Add to watchlist

BRIDGEBIO PHARMA INC's ticker is and the CUSIP is 10806X902. A total of 4 filers reported holding BRIDGEBIO PHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of BRIDGEBIO PHARMA INC
ValueSharesWeighting
Q2 2023$156,520
-49.2%
9,100
-51.1%
0.00%–
Q1 2023$308,000
-69.2%
18,600
-69.0%
0.00%–
Q4 2021$1,001,000–60,000–0.00%–
 Download
Other shareholders
BRIDGEBIO PHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 160,200$1,626,0000.00%
SIMPLEX TRADING, LLC 125,200$1,270,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of BRIDGEBIO PHARMA INC shareholders